Empowerment Training on Type 2 Diabetes Patients on Empowerment Levels and Clinical Findings
Study Details
Study Description
Brief Summary
In this study, the effect of nurse-led empowerment training given to patients with Type 2 Diabetes on clinical findings and empowerment behaviors will be investigated.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The research is a randomized controlled design research that includes a pre-test/post-test design. The primary outcome expected in the research; change in empowerment behaviors as a result of the training given; secondary outcomes are changes in clinical findings.
The research universe; All Type 2 diabetes patients who applied to the endocrinology polyclinic of a private hospital in Eskisehir city center between March-July 2019 consisted of. In the study, the sample was randomly selected, and it was aimed to reach all patients with Type 2 diabetes who were 18 years of age and older, with a diagnosis period of one year or more.
In the study, patients were randomly assigned to the intervention group, which included 6 weeks of training, or to the control group, which was on a 6-week waiting list. It used a question-based format to address the educational, behavioral, and psychosocial needs of patients within the scope of a 12-hour empowerment program that lasted for 6 weeks, 2 hours a week.
Education (DSMS (Developing Empowerment-Based Diabetes Self-Management Support)) is planned as stated literature.
Purpose of education: Empowerment as a philosophy of care emphasizes a collaborative approach to facilitating behavior change for patients themselves. Empowerment approach; Goal setting is a five-step process that provides patients with the knowledge and clarity they need to develop and achieve their diabetes and lifestyle goals. The first two steps are to identify the problem and identify patients' beliefs, thoughts, and feelings that may support or hinder their efforts. The third step is to determine the long-term goals expected from patients. In this step, patients are then expected to make a behavioral change that will help them achieve their long-term goals. The last step is for patients to evaluate their efforts and determine what they have learned in the process. Empowerment training was determined within the framework of this process.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Intervention group Type 2 Diabetes Mellitus patients who received a empowerment training program for 6 weeks, 2 hours a week |
Behavioral: Diabetes self- management education (DSME) program
We offered a two-hour course each week, comprising of two sessions of lectures (40 minutes each), two breaks (10 min each) and interactive session (20 min). In the interactive session, patients could communicate with each other in groups or raise any questions to the investigators.
|
| No Intervention: Control group Type 2 Diabetes Mellitus patients who did not receive a empowerment training program |
Outcome Measures
Primary Outcome Measures
- improvement in The Diabetes Empowerment Scale scores [3 months]
The Diabetes Empowerment Scale (DES-28) questionnaires consist of 28 items with 3 subscales, with each item rated along a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree). The range of score was divided in three subgroups as low (28-65 scores), middle (66-103) and high (104-140). All items have been scored so that a higher value indicates stronger empowerment.
Secondary Outcome Measures
- improvement in HbA1c levels [6 months]
decrease in HbA1c (mmol/mol)
- improvement in fasting glucose [6 months]
decrease in fasting glucose (mmol/L)
- improvement in low density lipoprotein [6 months]
decrease in low density lipoprotein (mmol/L)
- improvement in triglyceride [6 months]
decrease in triglyceride (mmol/L)
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients with Type 2 Diabetes Mellitus diagnosed more than 1 year ago
Exclusion Criteria:
-
Mental retardation
-
Dementia
-
Deafness
-
Blindness
-
Psychiatric illness
-
Steroid use
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Acıbadem Hospital | Eskişehir | Turkey | 26170 |
Sponsors and Collaborators
- Kutahya Health Sciences University
Investigators
- Study Chair: müzelfe bıyık, Ms, Eskişehir Osmangazi University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- DM Training